Technology | Ultrasound Imaging | December 14, 2016

Clarius Wireless Ultrasound Receives FDA 510(k) Clearance

C3 and L7 models are compatible with the latest iOS and Android smartphones and tablets

Clarius Mobile Health, C3, L7, wireless ultrasound scanners, FDA 510k clearance

December 14, 2016 — Clarius Mobile Health announced the U.S. Food and Drug Administration (FDA) has cleared the C3 and L7 Clarius Wireless Ultrasound Scanners, which are compatible with the latest iOS and Android smartphones and tablets.

"Clarius is the future of patient care. The image quality is amazing for any scanner, much less one that fits in my pocket," said Steven Steinhubl, M.D., director of digital medicine at the Scripps Translational Science Institute.  "The ability to wirelessly connect it to any Apple or Android device means that anyone on my team can use it with whatever they already carry around in their pocket."

Introduced in March 2016, Clarius Ultrasound Scanners are intended for clinicians to conduct quick scans and to guide short procedures at the bedside. The Clarius C3 multipurpose ultrasound scanner is designed to image the abdomen and lungs; it also incorporates a virtual phased array for quick scans of the heart. The Clarius L7 is ideal for guiding procedures and imaging superficial structures.

Unlike other app-based ultrasound systems that draw power from a connected smart device, Clarius Scanners are powered by a rechargeable battery, which is easily exchanged when running low. Two batteries and a charger are delivered with each scanner. Built with a magnesium case, the devices are designed to withstand challenging environments and are water submersible for easy cleaning and disinfection.

"Having used Clarius in an educational setting, I am excited about its potential to put ultrasound into the hands of more clinicians," said Thomas Cook, M.D., of 3rd Rock Ultrasound. "Besides being portable and easy to use, I'm very impressed by the image quality produced by such a compact ultrasound machine."

As a direct-to-professionals e-commerce company, Clarius aims to make ultrasound systems affordable and easily accessible to medical professionals. To facilitate online sales, the company offers customers the ability to return the product after a one-week trial period for a small handling fee. The company's e-commerce portal is supported by a telesales team.  Clarius Scanners are also available from a network of sales partners across the country.

For more information: www.clarius.me

Related Content

Ultrasound-guided carpal tunnel release quickly improves hand function and reduces hand discomfort, making the procedure a safe, effective, and less invasive alternative to traditional open or endoscopic surgery

Patients answered three questionnaires (Quick-Disabilities of the Arm, Shoulder, and Hand [QDASH] and two parts of the Boston Carpal Tunnel Syndrome Questionnaire: symptom severity [BCTSQ-SS] and functional status [BCTSQ-FS] scales) assessing the affected wrist's function and discomfort immediately pre-procedure, 2 weeks post-procedure, and at least one year post-procedure. Infographic courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Ultrasound Imaging | September 17, 2020
September 17, 2020 — According to ARRS' American Journal of Roentgenology (AJR),...
Feature | Coronavirus (COVID-19) | September 15, 2020
September 15, 2020 — The world is facing a global pandemic with unknown implications, but it is now well known ...
Videos | Coronavirus (COVID-19) | September 15, 2020
Case is a 6-month-old infant boy admitted to hospital due to respiratory distress then worsened by a pericardial effu
The Epiq CVxi being used for TEE imaging in the cath lab. The system brings together advanced image quality, quantification and intelligence specifically for the cardiologist.

The Epiq CVxi being used for TEE imaging in the cath lab. The system brings together advanced image quality, quantification and intelligence specifically for the cardiologist.

News | Ultrasound Imaging | September 15, 2020
September 15, 2020 — Philips Healthcare recently introduced the latest addition to its portfolio of dedicated...
High-intensity focused ultrasound (HIFU), a technology used to treat localized prostate cancer, has shown adequate control of prostate cancer while avoiding major side effects of surgery or radiation therapy, according to a new study in The Journal of Urology, Official Journal of the American Urological Association

Getty Images

News | Prostate Cancer | September 08, 2020
September 8, 2020 — Approved by the US Food and Drug Administration (FDA) in 2015 for prostate tissue ablation, the h
Videos | Ultrasound Imaging | August 13, 2020
This is a tutorial video on how to perform an ...